We are live on
!
Find out more
Man Group Portfolio holdings
AUM
$55.1B
1-Year Est. Return
24.23%
This Fund
S&P 500
This Quarter
Est. Return
+12.77%
1 Year Est. Return
+24.23%
3 Year Est. Return
+82.67%
5 Year Est. Return
+105.49%
10 Year Est. Return
–
AUM
$52.5B
AUM Growth
+$13.1B
(+33%)
Cap. Flow
+$7.72B
Cap. Flow
% of AUM
14.72%
Top 10 Holdings %
Top 10 Hldgs %
17.31%
Holding
2,462
New
319
Increased
921
Reduced
776
Closed
312
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.09B |
| 2 |
NVIDIA
NVDA
|
+$436M |
| 3 |
Apple
AAPL
|
+$415M |
| 4 |
Microsoft
MSFT
|
+$396M |
| 5 |
Bristol-Myers Squibb
BMY
|
+$270M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Booz Allen Hamilton
BAH
|
+$120M |
| 2 |
Walt Disney
DIS
|
+$115M |
| 3 |
Wingstop
WING
|
+$89.6M |
| 4 |
Cisco
CSCO
|
+$88.1M |
| 5 |
Amphenol
APH
|
+$84.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.78% |
| 2 | Healthcare | 10.33% |
| 3 | Financials | 10.22% |
| 4 | Consumer Discretionary | 10.18% |
| 5 | Industrials | 7.64% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1701
Ibotta
IBTA
$611M
| $529K | ﹤0.01% |
+14,442
| New | +$675K |
|
1702
VanEck High Yield Muni ETF
HYD
$4.44B
| $527K | ﹤0.01% |
10,494
-105,965
| -91% | -$5.29M |
|
1703
DNOW Inc
DNOW
$2.63B
| $526K | ﹤0.01% |
35,452
-91,564
| -72% | -$1.4M |
|
1704
Vale
VALE
$62.9B
| $522K | ﹤0.01% |
53,782
-5,200,811
| -99% | -$49M |
|
|
NEXN
1705
Nexxen International
NEXN
$547M
| $522K | ﹤0.01% |
+50,153
| New | +$510K |
|
1706
Avanos Medical
AVNS
$1.17B
| $519K | ﹤0.01% |
42,441
+21,143
| +99% | +$266K |
|
1707
First Bank
FRBA
$451M
| $518K | ﹤0.01% |
33,505
+1,628
| +5% | +$23.6K |
|
1708
Prologis
PLD
$138B
| $518K | ﹤0.01% |
+4,930
| New | +$517K |
|
1709
RingCentral
RNG
$4.05B
| $518K | ﹤0.01% |
+18,279
| New | +$472K |
|
1710
Insight Enterprises
NSIT
$3.55B
| $517K | ﹤0.01% |
3,743
| – | – |
|
1711
BGC Group
BGC
$5.58B
| $516K | ﹤0.01% |
+50,457
| New | +$463K |
|
1712
Royalty Pharma
RPRX
$26.1B
| $513K | ﹤0.01% |
14,238
-64,673
| -82% | -$2.14M |
|
1713
Steven Madden
SHOO
$3.12B
| $513K | ﹤0.01% |
21,390
+12,354
| +137% | +$290K |
|
|
AVDL
1714
DELISTED
Avadel Pharmaceuticals
AVDL
| $513K | ﹤0.01% |
57,931
+29,149
| +101% | +$256K |
|
1715
CALL
State Street Health Care Select Sector SPDR ETF
XLV
$42.1B
| $512K | ﹤0.01% |
3,800
-6,800
| -64% | -$918K |
|
1716
Digi International
DGII
$2.52B
| $501K | ﹤0.01% |
14,376
+639
| +5% | +$19.6K |
|
1717
4D Molecular Therapeutics
FDMT
$526M
| $501K | ﹤0.01% |
134,932
+82,980
| +160% | +$292K |
|
1718
Turning Point Brands
TPB
$1.47B
| $500K | ﹤0.01% |
6,604
-4,593
| -41% | -$312K |
|
1719
SoundThinking
SSTI
$107M
| $498K | ﹤0.01% |
38,166
+4,588
| +14% | +$71.5K |
|
1720
Ouster
OUST
$2.29B
| $495K | ﹤0.01% |
+20,401
| New | +$248K |
|
|
KE
1721
Kimball Electronics
KE
$598M
| $494K | ﹤0.01% |
+25,689
| New | +$430K |
|
1722
Qorvo
QRVO
$7.63B
| $492K | ﹤0.01% |
5,800
-800
| -12% | -$57.8K |
|
1723
Enerpac Tool Group
EPAC
$1.77B
| $492K | ﹤0.01% |
12,133
-77
| -0.6% | -$3.24K |
|
|
RNAM
1724
DELISTED
Avidity Biosciences
RNAM
| $492K | ﹤0.01% |
17,323
-132,932
| -88% | -$3.96M |
|
1725
Parsons
PSN
$6.28B
| $490K | ﹤0.01% |
6,830
-243,187
| -97% | -$16.1M |
|
Similar funds
Man Group's Q2 2025 Portfolio in Review
As of Q2 2025, Man Group held 2,462 positions worth $52.5B, up 33% from $39.4B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Man Group deployed $7.72B of net new capital in Q2 2025, opening 319 new positions and adding to 921 existing holdings. Its largest new stake was State Street SPDR S&P 500 ETF Trust: 1,900,024 shares worth $1.17B.
By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 18% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Booz Allen Hamilton, an estimated $120M trimmed.
- Man Group's largest Q2 2025 buy was State Street SPDR S&P 500 ETF Trust: 1,900,024 shares worth $1.17B.
- Man Group added most to NVIDIA in Q2 2025, an estimated $436M increase.
- Man Group's biggest Q2 2025 reduction was Booz Allen Hamilton, cutting an estimated $120M.
- Man Group fully exited Intra-Cellular Therapies Inc. in Q2 2025, selling an estimated $81.9M.
- Man Group's ten largest holdings make up 17% of its $52.5B portfolio in Q2 2025.
- Man Group opened 319 new positions and closed 312 in Q2 2025.
- Man Group's portfolio value rose 33% quarter-over-quarter to $52.5B.
Based on Man Group's 13F filing for Q2 2025, filed 14 Aug 2025.